Form 4 holding
Chief Executive Officer, Director
Chemomab Therapeutics Ltd.
- Security class
- American Depositary Shares
- Shares / value
- 18,750
- Estimated value
- $1,593,873
- Report date
- 29 May 2026
- Price
- $5.03
- Ownership
- Direct